SPOTLIGHT: Market expands for infectious diseases


An increasing amount of global travel has caused several infectious diseases, such as Yellow Fever and West Nile Virus, to surface in developed countries after largely being restricted to underdeveloped areas. And that trend has opened up a channel for vaccine manufacturers to develop products for advanced countries. Release

Suggested Articles

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.

AZ is among the companies leading the COVID-19 vaccine race, and after agreeing first to supply the U.K., it's now in talks for delivery worldwide.